Dr. Pruthi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8300 Floyd Curl Dr
San Antonio, TX 78229Phone+1 210-450-9600Fax+1 210-450-9567
Education & Training
- University of ManitobaClass of 2011
Certifications & Licensure
- TX State Medical License 2016 - 2025
- American Board of Urology Urology
Clinical Trials
- Financial Toxicity and Quality of Life in Patients With TGCT Start of enrollment: 2023 Mar 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma.Abhishek Tripathi, Catherine M Tangen, Melissa Plets, Xiaochen Li, Maria Tretiakova
BJU International. 2024-10-01 - 1 citationsAdjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.Shuchi Gulati, Catherine Tangen, Christopher W Ryan, Ulka N Vaishampayan, Brian M Shuch
JAMA Network Open. 2024-08-01 - Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium.Deepak K Pruthi, Gregor Miller, Donna P Ankerst, Matthias Neumair, Umberto Capitanio
The Journal of Urology. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: